• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

ACTRIMS Forum 2026 survey

February 3, 2026  

PRL detected in optic chiasm

January 30, 2026  

BTK inhibitors – a look ahead

January 20, 2026  

High-efficacy DMTs for MS: the year in review

December 1, 2025  

Ocrelizumab use throughout the MS clinical course: highlights from ECTRIMS 2025

October 15, 2025  

Early use and long-term safety of ofatumumab: highlights from ECTRIMS 2025

October 7, 2025  

ECTRIMS 2025 HIGHLIGHTS – SATURDAY, SEPTEMBER 27, 2025

September 27, 2025  

ECTRIMS 2025 HIGHLIGHTS – FRIDAY, SEPTEMBER 26, 2025

September 26, 2025  

ECTRIMS 2025 HIGHLIGHTS – THURSDAY, SEPTEMBER 25, 2025

September 25, 2025  

ECTRIMS 2025 survey

September 4, 2025  
Previous
1
2
3
4
5
Next

Browse by Topic

  • MSToronto2026 (6)
  • MS (450)
  • CLINICAL CASES (22)
  • EAN 2026 (2)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • AES 2025 (1)
  • EPILEPSY (38)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • MSToronto 2026 Highlights – Friday, October 23, 2026 posted on October 23, 2026
  • MSToronto 2026 Highlights – Thursday, October 22, 2026 posted on October 22, 2026
  • New ECTRIMS/EAN recommendations for vaccination in MS patients posted on September 5, 2023
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions